In Brazil, researchers at the University of São Paulo (USP) and the Pernambuco division of Oswaldo Cruz Foundation (FIOCRUZ) are developing a Zika vaccine. The formulation was tested on mice and found to be efficacious, ...
Apr 18, 2024
0
28
Metabolic health (normal blood pressure, blood sugar and cholesterol levels, among other factors) influences the effectiveness of influenza vaccinations. Vaccination is known to be less effective in people with obesity compared ...
Apr 18, 2024
0
13
Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.
Apr 15, 2024
0
116
University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs—the way TB enters the body.
Apr 15, 2024
0
9
A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).
Apr 12, 2024
0
60
A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.
Apr 9, 2024
0
64
Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to opioids, like fentanyl and heroin, as well as cocaine—leading ...
Apr 3, 2024
0
42
Scientists have been searching for the optimal coronavirus vaccine since the COVID-19 pandemic started. The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; ...
Apr 1, 2024
0
278
A second-generation melanoma vaccine being developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows. Interestingly, the benefit of the ...
Mar 29, 2024
0
50
Adults with certain socio-demographic and clinical characteristics may have weaker antibody responses to COVID-19 vaccination, which could leader to a higher risk of infection, according to a recent study published in Nature ...
Mar 22, 2024
0
38
